Download PDF
1 / Pages

Other users also viewed these articles

Prevalence and Determinants of COPD in Spain: EPISCAN II Joan B. Soriano; Inmaculada Alfageme; Marc Miravitlles; Pilar de Lucas; Juan José Soler-Cataluña; Francisco García-Río; Ciro Casanova; José Miguel Rodríguez González-Moro; Borja G. Cosío; Guadalupe Sánchez; Julio Ancochea;
Arch Bronconeumol. 2021;57:61-9
What to Do When Endobronchial Volume Reduction Treatment Fails Selene Cuenca Peris; Raquel Martínez Tomás; Andrés Briones Gómez; Enrique Cases Viedma;
Arch Bronconeumol. 2024;60:319-20
Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience Juan P. de-Torres; Ciro Casanova; José M. Marín; Carlos Cabrera; Marta Marín; Ana Ezponda; Borja G. Cosio; Cristina Martínez; Ingrid Solanes; Antonia Fuster; Myriam Calle; Germán Peces-Barba; Carolina Gotera; Nuria Feu-Collado; Alicia Marin; Ana Belén Alcaide; Matilde Sangro; Gorka Bastarrika; Bartolome R. Celli;
Arch Bronconeumol. 2024;60:10-5